Carlos Gómez Martín

3PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 09, 2026
A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma.

|Jun 28, 2025
Correction: Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).

Maria Alsina Maqueda, Ana Teijo Quintáns, Miriam Cuatrecasas

|Mar 12, 2025
Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).

Maria Alsina Maqueda, Ana Teijo Quintáns, Miriam Cuatrecasas

Pageof 1

Frequent Collaborators

2 joint publications

Maria Alsina Maqueda

2 joint publications

Ana Teijo Quintáns

2 joint publications

Miriam Cuatrecasas

2 joint publications

Maria Jesús Fernández Aceñero